markeriterapia
Markeriterapia is a term that refers to the use of marker molecules in therapeutic applications. These marker molecules, often specific proteins, nucleic acids, or antibodies, are designed to target diseased cells or specific biological pathways within the body. The goal of markeriterapia is to deliver therapeutic agents with greater precision, thereby enhancing efficacy and minimizing side effects associated with conventional treatments.
The development of markeriterapia relies heavily on advances in molecular biology and immunology. By identifying unique
Examples of markeriterapia include antibody-drug conjugates (ADCs), where an antibody recognizes a specific cell surface marker